课题基金 / 基金详情

GLYCOSYLATION STATUS ASSAYS FOR DIAGNOSTIC TUMOR MARKERS

GLYCOSYLATION STATUS ASSAYS FOR DIAGNOSTIC TUMOR MARKERS
诊断肿瘤标志物的糖基化状态测定
批准号:
3493251
负责人:
DAVID F SMITH
金额:
$5.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1992
资助国家:
美国
项目状态:
已结题
起止时间:
1992-08-14 至 1993-01-31

项目摘要

项目成果

DAVID F SMITH的其他基金

相似基金

相关文献

中文摘要
翻译
血清或尿液中升高的某些血清糖蛋白 癌症患者被认为是肿瘤标志物。对网络安全问题的分析 其中许多糖蛋白上的寡糖侧链,包括 甲胎蛋白、γ-谷氨酰转肽酶与人类慢性 来自恶性组织的促性腺激素证明 它们的糖基化状态与非恶性的明显不同。 对口单位。因此,关于某些糖基化状态的信息 血清和尿糖蛋白可能比糖蛋白更有诊断意义 测量这些标记物的水平。目前的技术 可用于测量糖基化状态使用以下两种详细的化学物质 分析或凝集素亲和层析。这些程序,尽管 优雅,复杂,耗时,昂贵,而且不容易 可自动化的。我们开发了一种新型的固相生物发光 微量平板格式的免疫分析(BIA) 灵敏,易于使用,易于适应筛查和临床 使用。此第一阶段提案的具体目标是制定BIA,以 监测已显示糖基化状态的AFP的糖形式 有可能被诊断为人和人的肝细胞癌 在动物模型中。此阶段I应用程序将演示 建立其他肿瘤标志物糖基化状态检测方法的可行性 以及开发用于廉价监测的检测试剂盒的技术 其他糖蛋白的糖基化状态。
英文摘要
Certain serum glycoproteins that are elevated in the serum or urine of cancer patients are considered to be tumor markers. Analyses of the oligosaccharide side-chains on many of these glycoproteins, including a-fetoprotein (AFP), gamma-glutamyltranspeptidase and human chronic gonadotropin, which are derived from malignant tissues, demonstrate that their glycosylation status is markedly different from their non-malignant counterparts. Thus, information about the glycosylation status of certain serum and urinary glycoproteins may have more diagnostic significance than measurements of levels of these markers. The techniques presently available to measure glycosylation status employ either detailed chemical analyses or lectin-affinity chromatography. These procedures, although elegant, are complex, time consuming, expensive, and not readily automatable. We have developed novel solid phase bioluminescent immunoassays (BIA) in a microtiter plate format that are extremely sensitive, easy to use, and readily adaptable for screening and clinical use. The specific aim of this phase I proposal is to develop a BIA to monitor the glycoforms of AFP whose glycosylation status has been shown to be potentially diagnostic for hepatocellular carcinoma both in humans and in an animal model. This Phase I application will demonstrate the feasibility to develop glycosylation status assays for other tumor markers and the technology to develop assay kits for inexpensive monitoring of the glycosylation status of other glycoproteins.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
BIOLUMINESCENT ASSAY FOR QUANTIFYING PCR PRODUCTS
  • 批准号:
    2004759
  • 项目类别:
  • 资助金额:
    $9.94万
  • 财政年份:
    1996
  • 负责人:
    DAVID F SMITH
  • 依托单位:
CRYPTOSPORIDOSIS--A BIOLUMINESCENT CRYPTOSPORIDIUM ASSAY
  • 批准号:
    2075775
  • 项目类别:
  • 资助金额:
    $9.3万
  • 财政年份:
    1995
  • 负责人:
    DAVID F SMITH
  • 依托单位:
BIOLUMINESCENT DETECTION OF MYCOBACTERIUM TUBERCULOSIS
  • 批准号:
    2074152
  • 项目类别:
  • 资助金额:
    $8.55万
  • 财政年份:
    1995
  • 负责人:
    DAVID F SMITH
  • 依托单位:
CONTROLLED EXPRESSION OF NEOGLYCANS
  • 批准号:
    2183513
  • 项目类别:
  • 资助金额:
    $16.43万
  • 财政年份:
    1991
  • 负责人:
    DAVID F SMITH
  • 依托单位:
海外基金